He Y - Search Results

1

Intensive treatment of triple negative breast cancer with residual positive axillary lymph node after neoadjuvant chemotherapy.

Wang X, He Y, Li J, Wang T, Fan Z, Ouyang T. Wang X, et al. Among authors: he y. BMC Womens Health. 2024 Nov 27;24(1):629. doi: 10.1186/s12905-024-03441-0. BMC Womens Health. 2024. PMID: 39604957 Free PMC article. Clinical Trial.

2

[Impact of response of positive axillary nodes to neoadjuvant chemotherapy on breast cancer survival].

Wang X, He YJ, Ying M, Li JF, Xie YT, Wang TF, Fan ZQ, Fan T, Ouyang T. Wang X, et al. Zhonghua Yi Xue Za Zhi. 2011 Aug 16;91(30):2116-9. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22093987 Chinese.

3

[Diagnostic value and health economic evaluation of ultrasound-combined fine-needle aspiration cytology in primary breast cancer].

He YJ, Li JF, Wang TF, Xie YT, Fan ZQ, Ouyang T. He YJ, et al. Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3288-90. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23328516 Chinese.

4

Value of pre-treatment biomarkers in prediction of response to neoadjuvant endocrine therapy for hormone receptor-positive postmenopausal breast cancer.

Ying M, He Y, Qi M, Dong B, Lu A, Li J, Xie Y, Wang T, Lin B, Ouyang T. Ying M, et al. Among authors: he y. Chin J Cancer Res. 2013 Aug;25(4):397-404. doi: 10.3978/j.issn.1000-9604.2013.08.01. Chin J Cancer Res. 2013. PMID: 23997526 Free PMC article.

5

[Analysis of associations between molecular subtypes and responses to neoadjuvant chemotherapy in primary breast cancer patients].

Zhou YJ, Ying M, He YJ, Liu YQ, Fan ZQ, Fan T, Li JF, Wang TF, Xie YT, Lu AP, Ouyang T. Zhou YJ, et al. Zhonghua Yi Xue Za Zhi. 2013 Jun 11;93(22):1711-5. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24124677 Chinese.

6

[Reliability of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 expression in breast cancer evaluated by immunohistochemistry].

Gu CS, Ying M, He YJ, Liu YQ, Dong B, Ouyang T, Lu AP. Gu CS, et al. Zhonghua Yi Xue Za Zhi. 2013 Aug 27;93(32):2571-3. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24351599 Chinese.

7

[Safety of omitting axillary lymph node dissection in primary breast cancer patients with negative sentinel lymph nodes].

Fan T, Ouyang T, Li JF, Xie YT, Fan ZQ, He YJ, Wang TF. Fan T, et al. Zhonghua Yi Xue Za Zhi. 2013 Oct 29;93(40):3220-2. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24405545 Chinese.

8

[Survival analysis for different molecular subtypes of breast cancers after treatment].

He YJ, Li JF, Wang TF, Xie YT, Fan ZQ, Wang LZ, Ying M, Ouyang T. He YJ, et al. Zhonghua Yi Xue Za Zhi. 2013 Dec;93(46):3663-6. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24534345 Chinese.

9

[Risk factors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node ≤ 2].

Gao Y, He Y, Fan Z, Ouyang T. Gao Y, et al. Among authors: he y. Zhonghua Yi Xue Za Zhi. 2014 Aug 13;94(30):2355-8. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25399977 Chinese.

10

[Risk factors for non-sentinel lymph node metastasis in patients after neoadjuvant chemotherapy].

Yang Y, He Y, Li J, Xie Y, Wang T, Fan Z, Fan T, Ouyang T. Yang Y, et al. Among authors: he y. Zhonghua Yi Xue Za Zhi. 2014 Sep 16;94(34):2661-4. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25511592 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,510 results

Search Page

Filters